Yes-Associated Protein Regulation of Adaptive Liver Enlargement and Hepatocellular Carcinoma Development in Mice
Marta A. Kowalik , Christian Saliba , Monica Pibiri , Andrea Perra
Hepatology 53 ( 6) 2086 -2096
59
2011
MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?†
Silvia Giordano , Amedeo Columbano
Hepatology 57 ( 2) 840 -847
261
2013
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival.
Sandra Mattu , Francesca Fornari , Luca Quagliata , Andrea Perra
Journal of Hepatology 64 ( 4) 891 -898
17
2016
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3
Vera P. Leoni , Giovanna M. Ledda-Columbano , Monica Pibiri , Christian Saliba
Journal of Hepatology 55 ( 5) 1069 -1078
7
2011
Met as a therapeutic target in HCC: Facts and hopes
Silvia Giordano , Amedeo Columbano
Journal of Hepatology 60 ( 2) 442 -452
97
2014
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra , Marta Anna Kowalik , Elena Ghiso , Giovanna Maria Ledda-Columbano
Journal of Hepatology 61 ( 5) 1088 -1096
192
2014
Cell-Autonomous and Non–Cell-Autonomous Mechanisms of HGF/MET–Driven Resistance to Targeted Therapies: From Basic Research to a Clinical Perspective
Simona Corso , Silvia Giordano
Cancer Discovery 3 ( 9) 978 -992
86
2013
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli , Simona Corso , Andrea Bertotti , Sebastijan Hobor
Cancer Discovery 3 ( 6) 658 -673
633
2013
Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis
Bénédicte Foveau , Frédéric Ancot , Catherine Leroy , Annalisa Petrelli
Molecular Biology of the Cell 20 ( 9) 2495 -2507
94
2009
Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells.
Fabrizio Montaldo , Antonella Maff� , Monica Morini , Douglas Noonan
Journal of Cellular Physiology 184 ( 2) 246 -254
19
2000
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
Carola Ponzetto , Alberto Bardelli , Zhu Zhen , Flavio Maina
Cell 77 ( 2) 261 -271
884
1994
Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line
Silvia Giordano , Maria Flavia Di Renzo , Radha P. Narsimhan , Luca Tamagnone
Journal of Cellular Biochemistry 38 ( 4) 229 -236
13
1988
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages.
Jose Rafael Sierra , Simona Corso , Luisa Caione , Virna Cepero
Journal of Experimental Medicine 205 ( 7) 1673 -1685
210
2008
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell–Intrinsic Transcriptional MSI Traits
Simona Corso , Claudio Isella , Sara E. Bellomo , Maria Apicella
Cancer Research 79 ( 22) 5884 -5896
18
2019
Sema4D induces angiogenesis through Met recruitment by Plexin B1.
Paolo Conrotto , Donatella Valdembri , Simona Corso , Guido Serini
Blood 105 ( 11) 4321 -4329
214
2005
Hepatocyte growth factor and its receptor are required for malaria infection
Margarida Carrolo , Silvia Giordano , Laura Cabrita-Santos , Simona Corso
Nature Medicine 9 ( 11) 1363 -1369
121
2003
MET Overexpression Turns Human Primary Osteoblasts into Osteosarcomas
Salvatore Patanè , Sofia Avnet , Nadia Coltella , Barbara Costa
Cancer Research 66 ( 9) 4750 -4757
92
2006
Molecular cancer therapy: can our expectation be MET?
Cristina Migliore , Silvia Giordano
European Journal of Cancer 44 ( 5) 641 -651
118
2008
Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene.
Giovanna Rege-Cambrin , Patrizia Scaravaglio , Franca Carozzi , Silvia Giordano
Cancer Genetics and Cytogenetics 64 ( 2) 170 -173
65
1992
Targeted therapies in cancer and mechanisms of resistance.
Simona Corso , Silvia Giordano
Journal of Molecular Medicine 92 ( 7) 677 -679
5
2014